<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://vettaintech.com/research/the-neural-wire-synchron-endovascular-bcis-and-the-race-to-rewire-the-human-mind-1786128724014</loc>
    <news:news>
      <news:publication>
        <news:name>Vetta Investments</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-07T18:54:15.000Z</news:publication_date>
      <news:title>The Neural Wire: Synchron, Endovascular BCIs, and the Race to Rewire the Human Mind</news:title>
      <news:keywords>[&quot;Synchron brain computer interface&quot;, &quot;endovascular BCIs&quot;, &quot;Stentrode technology&quot;, &quot;minimally invasive neurosurgery&quot;, &quot;jugular vein neural interface&quot;, &quot;brain computer interface market size&quot;, &quot;intimal hyperplasia medical devices&quot;, &quot;neuro-rehabilitation hardware&quot;, &quot;SYNC stock news&quot;, &quot;how do endovascular BCIs work&quot;</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://vettaintech.com/insights/digital-ramparts-fortifying-against-quantum-shadows-1786100645857</loc>
    <news:news>
      <news:publication>
        <news:name>Vetta Investments</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-07T11:04:05.000Z</news:publication_date>
      <news:title>Digital Ramparts: Fortifying Against Quantum Shadows</news:title>
      <news:keywords>quantum computing cybersecurity investment, zero trust architecture market growth, post-quantum cryptography investment opportunities, digital security fortification technologies, Vetta Investments, V-Rank Alpha, separately managed accounts, algorithmic equity strategy, how to invest in cybersecurity, what is zero trust architecture</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://vettaintech.com/insights/small-cap-biotech-outperformance-rare-disease-innovation-fuels-m-a-targets-1786006933900</loc>
    <news:news>
      <news:publication>
        <news:name>Vetta Investments</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-06T09:02:26.000Z</news:publication_date>
      <news:title>Small-Cap Biotech Outperformance: Rare Disease Innovation Fuels M&amp;A Targets</news:title>
      <news:keywords>[&quot;small-cap biotech rare disease M&amp;A targets&quot;, &quot;rare disease innovation fuels biotech M&amp;A&quot;, &quot;small-cap biotech outperformance M&amp;A strategy&quot;, &quot;biotech M&amp;A rare disease&quot;, &quot;small-cap biotech investing&quot;, &quot;rare disease innovation&quot;, &quot;Vetta Investments&quot;, &quot;V-Rank Alpha&quot;, &quot;separately managed accounts&quot;, &quot;algorithmic equity strategy&quot;</news:keywords>
    </news:news>
  </url>
</urlset>